No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US Stock MarketDetailed Quotes
IFRX InflaRx
- 1.260
- -0.005-0.40%
Close Apr 18 16:00 ET
- 1.240
- -0.020-1.59%
Post 17:08 ET
74.19MMarket Cap-1518P/E (TTM)
1.420High1.250Low120.60KVolume1.260Open1.265Pre Close159.34KTurnover0.25%Turnover RatioLossP/E (Static)58.88MShares5.20052wk High0.68P/B61.51MFloat Cap1.14052wk Low--Dividend TTM48.82MShs Float53.100Historical High--Div YieldTTM13.44%Amplitude0.776Historical Low1.321Avg Price1Lot Size
Full Hours
- 5D
- 1D
- 1W
- 1M
- 1Q
- 1Y
Trade Overview
Unit: --
Capital Trend
IntradayDayWeekMonth
No Data
News
InflaRx N.V. Announces 2024 AGM Details
Investor Optimism for InflaRx's INF904: Assessing Potential in CSU and HS Markets
LifeSci Capital Reaffirms Their Hold Rating on InflaRx (IFRX)
Express News | HC Wainwright & Co. Reiterates Buy on InflaRx, Maintains $8 Price Target
Buy Rating Justified for InflaRx Despite Earnings Miss: Financial Stability and INF904's Market Potential
InflaRx Advances Anti-Inflammatory Therapeutics
Comments
$InflaRx(IFRX.US$ getting interesting phase 1 went good
1
I like pstv only
📈💥 Let's seize Friday! Yesterday we witnessed a ticker surge with a 44.24% LONG MOVE. Today's focus:
✅1️⃣ HOWL Long > 2.73 Short < 2.61
✅2️⃣ NVOS Long > 0.3300 Short < 0.3095
✅3️⃣ CYTO Long > 0.2035 Short < 0.1855
✅4️⃣ PSTV Long > 1.64 Short < 1.49
✅5️⃣ IFRX Long > 1.62 Short < 1.53
✅6️⃣ FUBO Long > 3.20 Short < 2.99
✅1️⃣ HOWL Long > 2.73 Short < 2.61
✅2️⃣ NVOS Long > 0.3300 Short < 0.3095
✅3️⃣ CYTO Long > 0.2035 Short < 0.1855
✅4️⃣ PSTV Long > 1.64 Short < 1.49
✅5️⃣ IFRX Long > 1.62 Short < 1.53
✅6️⃣ FUBO Long > 3.20 Short < 2.99
ColumnsWeekly FDA Drug Pipeline Calendar (April 10 - April 14)
Hello mooers, welcome to another week of the FDA calendar. Here are what happened last week and what's coming up this week.
BIGGEST MOVERS FROM THIS WEEK
The FDA has granted Emergency Use Authorization (EUA) for Gohibic (vilobelimab) to $InflaRx(IFRX.US$ for the treatment of COVID-19 in hospitalized adults, provided it is initiated within 48 hours of receiving invasive mechanical ventilation (IMV) or extracorporeal membrane oxygenation (E...
BIGGEST MOVERS FROM THIS WEEK
The FDA has granted Emergency Use Authorization (EUA) for Gohibic (vilobelimab) to $InflaRx(IFRX.US$ for the treatment of COVID-19 in hospitalized adults, provided it is initiated within 48 hours of receiving invasive mechanical ventilation (IMV) or extracorporeal membrane oxygenation (E...
14
2
Read more
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg